Legend Biotech's GAAP loss for 3 months of 2022 was $41.087 million, down 49.2% from $80.899 million in the previous year. Revenue tripled to $40.827 million from $13.682 million a year earlier.
Legend Biotech's GAAP loss for 3 months of 2022 was $41.087 million, down 49.2% from $80.899 million in the previous year. Revenue tripled to $40.827 million from $13.682 million a year earlier. 
investors.legendbiotech.com
English (US) 